Oxytocin: 71 Nasal-Spray Trials, and None for What It Is Sold For

Oxytocin turns up on peptide comparison tables, and it is the entry most likely to mislead — because almost everything said about it is true of a product that is not the one being sold.

Two different things sharing a name

The medicine. Injectable oxytocin is a long-approved prescription drug used in obstetrics, administered in hospital with monitoring. It has a serious risk profile in that setting, which is why it is used the way it is used.

The peptide-market product. An intranasal spray, self-administered, bought online, taken for libido, connection or anxiety.

What intranasal oxytocin has actually been tested for

• Randomised trials, any indicationautism, obesity, social cognition
  71
• Randomised trials, sexual functionthe marketed use
  0

Counted August 2026. Intranasal oxytocin is genuinely well studied - the research just is not about the thing it is sold for here. The zero is a search for randomised trials of intranasal oxytocin and erectile function, libido or sexual function.

This is an unusually clean version of the pattern this site keeps finding. Oxytocin is not under-researched — there is a substantial randomised literature on the intranasal route, including work in autism spectrum conditions Anagnostou 2014 - Anagnostou E, Soorya L, Brian J et al. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res. 2014;1580:188-98. (opens PubMed in a new tab) and obesity Balestrino 2023 - Balestrino R, Losa M, Albano L et al. Intranasal oxytocin as a treatment for obesity: safety and efficacy. Expert Rev Endocrinol Metab. 2023;18(4):295-306. (opens PubMed in a new tab), and a review of safety, side effects and subjective reactions MacDonald 2011 - MacDonald E, Dadds MR, Brennan JL et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011;36(8):1114-26. (opens PubMed in a new tab).

None of it is about libido.

On safety, precisely

The published safety work describes the doses and durations used in trials — supervised, time-limited, in people who were being monitored MacDonald 2011 - MacDonald E, Dadds MR, Brennan JL et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011;36(8):1114-26. (opens PubMed in a new tab).

That is not the same claim as “safe to take indefinitely, at whatever dose, from a vial you bought online”. The first is evidence; the second is an extrapolation with nothing under it.

Status

References

Bibliographic detail is fetched from PubMed, not written by us - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than our judgement.

1. 1.Anagnostou E, Soorya L, Brian J et al. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res. 2014;1580:188-98.ReviewPMID 24508578
2. 2.Balestrino R, Losa M, Albano L et al. Intranasal oxytocin as a treatment for obesity: safety and efficacy. Expert Rev Endocrinol Metab. 2023;18(4):295-306.ReviewPMID 37232186
3. 3.MacDonald E, Dadds MR, Brennan JL et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011;36(8):1114-26.Systematic reviewPMID 21429671

Keep reading

Related guides

All guides →

• glp-1 peptidesGLP-1 Peptides: Approved Medicines and the LookalikesGLP-1 medicines cleared large trials and carry labelled uses. How to tell an approved product from a grey-market vial, and what FDA has said about the difference.2 min readRead guide→
• pt-141PT-141: An Approved Medicine, Sold Mostly to the Wrong PeopleBremelanotide has two Phase 3 trials behind it and an FDA approval. The trials were in premenopausal women; the grey market sells it to men. Both facts matter.3 min readRead guide→
• sermorelinSermorelin: What the Trials Studied, and Who They Studied It InApproved in 1997 for children with growth hormone deficiency, discontinued in 2008 - and the FDA says not for safety reasons. What the trials actually studied.6 min readRead guide→
• tesamorelinTesamorelin: The GHRH Peptide That Actually Cleared ApprovalSame class as CJC-1295 and sermorelin, but with 26 randomised trials and an FDA approval - for visceral fat in people with HIV. That specificity is the point.2 min readRead guide→
• thymosin alpha 1Thymosin Alpha-1: A Real Medicine, Tested in People Far Sicker Than You64 randomised trials and approvals outside the US. The newest and largest, in the BMJ, found no clear survival benefit. None of it studied healthy people.2 min readRead guide→
• best collagen peptidesBest Collagen Peptides: Choosing on the EvidenceStudied doses, third-party testing, molecular-weight marketing and cost per studied dose. The criteria that separate a good collagen from a well-advertised one.8 min readRead guide→